Format
Sort by

Send to:

Choose Destination

Results: 2

1.

Mimics of the dimerization domain of hepatocyte growth factor exhibit anti-Met and anticancer activity.

Kawas LH, Yamamoto BJ, Wright JW, Harding JW.

J Pharmacol Exp Ther. 2011 Nov;339(2):509-18. doi: 10.1124/jpet.111.185694. Epub 2011 Aug 22. Erratum in: J Pharmacol Exp Ther. 2014 Dec;351(3):685.

2.

The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor.

Yamamoto BJ, Elias PD, Masino JA, Hudson BD, McCoy AT, Anderson ZJ, Varnum MD, Sardinia MF, Wright JW, Harding JW.

J Pharmacol Exp Ther. 2010 Apr;333(1):161-73. doi: 10.1124/jpet.109.161711. Epub 2010 Jan 19. Erratum in: J Pharmacol Exp Ther. 2015 Feb;352(2):379.

Supplemental Content

Loading ...
Write to the Help Desk